Physician profile
Bryan A Cotton
NPI 1245327360
$305,967.78
in general payments reported to CMS, 2019-2025
12 companies · $121K in 2025
The $121K reported for 2025 was more than what 99% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $4,020 · 2021: $21K · 2022: $52K · 2023: $56K · 2024: $38K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $95K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Travel and Lodging: $24K · Food and Beverage: $6,761 · Honoraria: $4,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,000 · Gift: $809.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $94,653.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,812.50 |
| Travel and Lodging | $23,983.51 |
| Food and Beverage | $6,760.89 |
| Honoraria | $4,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,000.00 |
| Gift | $809.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $140,767.79 | 2021-2025 | Quikclot, Quikclot, Arrow |
| Haemonetics Corporation | $70,281.63 | 2019-2025 | Teg5000 Hemostasis Analyzer, Teg6s Hemostasis System, Cardiva Vascade 5f Vcs |
| Cerus Corporation | $49,873.30 | 2021-2025 | Intercept Blood System For Platelets, Intercept Blood System For Cryoprecipitation |
| Grifols USA, LLC | $19,720.15 | 2023-2024 | Thrombate III |
| Btg International INC. | $12,488.19 | 2024-2025 | |
| Grifols Shared Services North America, INC. | $6,416.84 | 2019 | |
| Arrow International, INC. | $6,000.00 | 2023 | Arrow |
| W. L. Gore & Associates, INC. | $166.06 | 2022 | |
| Medical Device Business Services, INC. | $150.00 | 2024 | Na |
| Tela Bio, INC. | $38.08 | 2019 | |
| Hemosonics LLC | $37.40 | 2024 | Qunatra Qplus System, Quantra Qplus System |
| Astrazeneca Pharmaceuticals Lp | $28.34 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Cotton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.